Etiotypes of persistent airflow obstruction in the general population in different age bins
The GOLD 2023 report identifies different causes (etiotypes) of COPD. Their prevalence in individuals in the general population with persistent airflow obstruction (PAO) is unknown. We aimed to describe it in different age bins.
Puedes leer el artículo completo aquí: https://erj.ersjournals.com/content/62/suppl_67/PA4146
We included 14,389 participants with valid post-bronchodilation spirometry from the general population cohort of the Austrian LEAD Study (NCT01727518). PAO was defined as FEV1/FVC<LLN GLI. No PAO was defined as LLN≤FEV1/FVC≤ULN.
Authors: , , , , , ,
Noticias relacionadas
The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
The diagnosis of COPD requires the demonstration of non-fully reversible airflow limitation by spirometry in the appropriate clinical context.
GOLD 2024: a brief overview of key changes
Since 2001 the GOLD publishes and updates every year a document that recommends how to best diagnose and manage COPD. The GOLD 2024 document has just been released and is available for free download in the GOLD website.
Biologics for COPD, Finally Here – Selected on NEJM Notable Articles of 2023
«Biologics for COPD — Finally Here» highlighted as one of the notable articles among the featured selections on NEJM Notable Articles of 2023
Artículos
Gold
- 768778·Alvar Agusti, Claus F. Vogelmeier – GOLD 2024: a brief overview of key changes
- 768973·Marie Grasl, Alvar Agusti, Caspar Schiffers, Owat Sunanta, Marie-Kathrin Breyer, Sylvia Hartl, Robab Breye -Etiotypes of persistent airflow obstruction in the general population in different age bins
- 769385·GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
- 769699·Alvar Agustí et al.- GOLD 2023: What’s New, Doc?
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría GOLD en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en artículo original.
COPD
- 759785·Richard Beasley et Al – Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
- 759788·Alvar Agustí, Rod Hughes, Eleni Rapsomaki, Barry Make, Ricardo Del Olmo, Alberto Papi, David Price, Laura Benton, Stefan Franzen, Jørgen Vestbo, Hana Mullerova – The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
- 759883·Alberto Papi, Rosa Faner, Ian Pavord, Federico Baraldi, Vanessa M McDonald, Mike Thomas, Marc Miravitlles, Nicholas Roche, Alvar Agustí. – From treatable traits to GETomics in airway disease: moving towards clinical practice
- 768799·Surya P Bhatt Richard Casaburi Alvar Agusti et Al. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
- 768885·Miguel Angel Martinez-García, Alvar Agustí. – Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease
